Skip to Content Skip to Search
GSK Logo linking to the homepage
  • Consumers
  • Healthcare professionals
    • Healthcare professionals
    • Interactions with prescribers
    • Collaborating on clinical trials and research
    • Transparency disclosures
      • Transparency disclosures
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2016-2018 transfer of value reports
  • Media
    • Media
    • Press releases
    • Resource centre
      • Resource centre
      • Malaria
      • Bioelectronics
      • If there are no scientists, who will cure diseases?
    • Supply updates
    • GSK's response to the COVID-19 pandemic
  • Contact us
    • Contact us
    • Our Locations
    • Patients and Healthcare Professionals
    • To report an adverse event
    • Media professionals
    • Careers
Menu
  • Behind the science
    • Behind the science
    • Tags A-Z
    • Patients & consumers
      • Patients & consumers
      • Giving babies a healthier start
      • International collaboration seeks to make childbirth safer in developing countries
      • The fight against Malaria (1)
      • Living every day with COPD
      • Crowd sourcing new treatments for malaria
    • Innovation
      • Innovation
      • Australian innovation pilot aims to reduce cost of vaccination in developing world
      • Innovation and collaboration with Monash University
      • The Value of Vaccines: Ensuring Australia keeps pace with community values and international practice
      • A comic book on vaccines
      • Pulling back the curtain on the PBS
      • Reconciliation Action Plan Progress Summary Q1 & Q2 2019
    • Our people
      • Our people
      • Karyn and Ahmed Trek for Kids
      • Save the Children
      • Employees helping communities
  • About us
    • About us
    • What we do
      • What we do
      • Pharmaceuticals
      • Vaccines
      • Consumer Healthcare
    • Policies, codes and standards
      • Policies, codes and standards
      • Industry

    • What we do

      We have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

    • Policies, codes and standards

      We believe how we deliver is just as important as what we deliver.

  • Products
    • Products
    • Our prescription medicines and vaccines
    • Our consumer healthcare products
    • ViiV Healthcare

    • Our consumer healthcare products

      We invest in building brands that consumers trust and come back to, time and time again.

    • Our prescription medicines and vaccines

      We produce treatments for a wide range of conditions as well as more than 30 vaccines worldwide.

    • ViiV Healthcare

      ViiV Healthcare is a global specialist HIV company dedicated to delivering advances in treatment and care for people living with HIV.

  • Careers
    • Careers
    • Search jobs and apply
    • Application tips
    • Working at GSK
      • Working at GSK
      • Employee volunteering
    • Students
      • Students
      • Application & Assessment
      • 2021 IBL Roles
    • Apprenticeships
      • Apprenticeships
      • Manufacturing and Process Industry Electrical Apprenticeship
      • Manufacturing and Process Industry Mechanical Fitter Apprenticeship
      • Development and benefits
      • Application and assessment
      • Parents and teachers
      • Maintenance Electrician - Adam
    • Researchers

    • Search jobs and apply

      Search for jobs and graduate positions across the world of GSK.

    • Application tips

      You're ready to apply. Read about how you can make your application stand out.

    • Working at GSK

      Our people are essential to our success. We focus on building their capabilities, and aim to support and empower them to be the best they can be.

    • Students

      Applications for the 2021 IBL intake have now closed. Thanks to all those who took the time to apply. We look forward to being back in contact with you.

  • Research
    • Research
    • Sharing our research
      • Sharing our research
      • Open Innovation
    • Trials in people
      • Trials in people
      • The race to richer data in clinical trials
    • Supporting research
      • Supporting research
      • Triathlete turned scientist Professor Mark Febbraio wins 40th GSK Award for Research Excellence
        • Triathlete turned scientist Professor Mark Febbraio wins 40th GSK Award for Research Excellence
        • Previous Winners
        • Alumni Members
        • GSK ARE: 40 years of support for Australian innovation
        • 2020 GSK Award for Research Excellence: Nominations now closed
        • Our winners reflect on the impact of the Award
      • Australian medical research community leads innovation for patients affected by respiratory conditions

    • Open Innovation

      Our open innovation strategy is designed to promote change beyond GSK by sharing expertise, resources intellectual property and know-how with external researchers and the scientific community in Australia and across the globe.

    • Sharing our research

      Regardless of whether clinical trials deliver positive or negative results, we are committed to sharing our research and collaborating with others so that we can advance our understanding of medicines and over-the-counter healthcare products.

    • Trials in people

      There are typically four phases to clinical trials. GSK Australia is involved in all aspects of these phases.

    • Supporting research

      We are committed to discovering and developing new medicines and vaccines, not just through our own clinical development, but also by investing in local research initiatives that are aligned with our vision and values.

    • Triathlete turned scientist Professor Mark Febbraio wins 40th GSK Award for Research Excellence

      Metabolic diseases are fast becoming a silent but global pandemic. Research demonstrates that over 60% of cancers are linked to obesity1 and Type 2 diabetes costs the Australian health care system more than $6 billion annually and affects more than 1.5 million Australians2.

  • Responsibility
    • Responsibility
    • Health for all
      • Health for all
      • Patient advocacy
    • Operating responsibly
      • Operating responsibly
      • Independent medical education
        • Independent medical education
        • Who can apply?
        • Educational activities funded in 2018
      • Healthcare Organisation Support Disclosure
        • Healthcare Organisation Support Disclosure
        • 2018
        • 2019
      • Patient and community disclosure
        • Patient and community disclosure
        • 2019
        • 2018
        • 2017
        • 2016
    • Our people
    • Our planet
    • Responsibility reports
    • Pollution incident response plan
    • Reconciliation Action Plan

    • Health for all

      We bring health benefits to people around the world through our open, flexible and collaborative approach to innovation and access to healthcare.

    • Operating responsibly

      How we do things is just as important as what we do. We have designed our values based culture to ensure we put patients and consumers first every time.

    • Our people

      Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.

    • Our planet

      We are working hard to reduce our environmental footprint. We aim to grow our business while protecting the natural; resources we need for the future.

    • Patient and community disclosure

      At GSK we are global advocates for increased transparency in the pharmaceutical industry. We believe in being ethical and responsible in everything we do.

    • Responsibility reports

      Access and download our corporate responsibility reports here.

    • Reconciliation Action Plan

      Our commitment to social responsibility, globally and in the Australian community, is embedded into the way we do business, and we are proud to build our Reconciliation Action Plan (RAP) into our ways of working.

Home

Prof Sinthia Bosnic-Anticevich among those leading the charge for innovation for patients affected by respiratory conditions

We are a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer...

Read our story

Our response to COVID-19

Environment - our new approach

Our News

Triathlete turned scientist wins major research award for uncovering potential obesity and diabetes treatment

03 December 2020

Following decision announced in July, GSK confirms Boronia manufacturing site to close at end of 2022

22 October 2020

GSK welcomes new Meningococcal B program to help protect those most at risk

01 July 2020

Greater flexibility for Australians with severe asthma with reimbursement of at-home, self-administration delivery of NUCALA® (mepolizumab)

01 June 2020

GSK Australia reports 2019 results (excluding Consumer Healthcare) to ASIC

30 April 2020

Tweets from GSK Australia

Tweets are currently unavailable

Follow us on Twitter

Join the conversation

  • Follow us on Twitter
  • Like us on Facebook
  • Watch us on YouTube
  • Visit us on Flickr
  • Follow us on LinkedIn

Working at GSK

Looking for a new job? Find out about working at GSK and how to apply.
  • Sitemap
  • Accessibility
  • Terms of Use
  • Privacy Policy
  • Procurement at GSK
    • Global
    Facebook
    • Global
    • Local
    Twitter
    • Global
    Youtube
    • Global
    Flickr
    • Global
    LinkedIn
    • Global
    Instagram Icon

© 2021 GlaxoSmithKline Australia Pty Ltd. ACN: 100 162 481. All rights reserved.
Registered office: 1061 Mountain Highway, Boronia, Victoria, 3155.
© 2021 GlaxoSmithKline Consumer Healthcare Australia Pty Ltd, ACN. 603 310 292. All rights reserved.
Registered office: 82 Hughes Avenue Ermington NSW 2115

You are leaving au.gsk.com

The information you are about to be referred to may not comply with the Australian regulatory requirements. Further information relevant to the Australian environment is available from the company or via the Product Information.

Cancel Continue